Amiloride Hydrochloride And Hydrochlorothiazide Tablet
FDA Label NDC 0555-0483

39 label sections · Submitted to the FDA by Teva Pharmaceuticals Usa, Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Teva Pharmaceuticals Usa, Inc. for the product Amiloride Hydrochloride And Hydrochlorothiazide (NDC 0555-0483). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, clinical pharmacology, amiloride hydrochloride, hydrochlorothiazide, indications and usage, hyperkalemia, antikaliuretic therapy or potassium supplementation, impaired renal function, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.